CR:DOI:255d85f5162682b856cfd0b102c7d93d

{{#scite:
 |reference=cohen2011ch
 |type=journal-article
 |title=Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States
 |author=Jeffrey I. Cohen;Elaine S. Jaffe;Janet K. Dale;Stefania Pittaluga;Helen E. Heslop;Cliona M. Rooney;Stephen Gottschalk;Catherine M. Bollard;V. Koneti Rao;Adriana Marques;Peter D. Burbelo;Siu-Ping Turk;Rachael Fulton;Alan S. Wayne;Richard F. Little;Mitchell S. Cairo;Nader K. El-Mallawany;Daniel Fowler;Claude Sportes;Michael R. Bishop;Wyndham Wilson;Stephen E. Straus|+sep=;
 |journal=Blood
 |publisher=American Society of Hematology
 |year=2011
 |volume=117
 |issue=22
 |pages=5835-5849
 |doi=10.1182/blood-2010-11-316745
 |subject=Cell Biology;Hematology;Immunology;Biochemistry|+sep=;
 |issn=0006-4971;1528-0020|+sep=;
 |retrieved-from=https://dx.doi.org/
 |retrieved-on=2022-02-18
}}